Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

1.

Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: a systematic review and meta-analysis.

Steen RG, Hamer RM, Lieberman JA.

Neuropsychopharmacology. 2005 Nov;30(11):1949-62. Review.

PMID:
16123764
[PubMed - indexed for MEDLINE]
Free Article
2.

Proton magnetic resonance spectroscopic imaging of cortical gray and white matter in schizophrenia.

Lim KO, Adalsteinsson E, Spielman D, Sullivan EV, Rosenbloom MJ, Pfefferbaum A.

Arch Gen Psychiatry. 1998 Apr;55(4):346-52.

PMID:
9554430
[PubMed - indexed for MEDLINE]
3.

Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.

Ohrmann P, Siegmund A, Suslow T, Pedersen A, Spitzberg K, Kersting A, Rothermundt M, Arolt V, Heindel W, Pfleiderer B.

J Psychiatr Res. 2007 Oct;41(8):625-34. Epub 2006 Sep 1.

PMID:
16949099
[PubMed - indexed for MEDLINE]
4.

Frontal lobe N-acetylaspartate correlates with psychopathology in schizophrenia: a proton magnetic resonance spectroscopy study.

Sigmundsson T, Maier M, Toone BK, Williams SC, Simmons A, Greenwood K, Ron MA.

Schizophr Res. 2003 Nov 1;64(1):63-71.

PMID:
14511802
[PubMed - indexed for MEDLINE]
5.

N-acetylaspartate (NAA) levels in selected areas of the brain in patients with chronic schizophrenia treated with typical and atypical neuroleptics: a proton magnetic resonance spectroscopy (1H MRS) study.

Szulc A, Galińska B, Tarasów E, Kubas B, Dzienis W, Konarzewska B, Poplawska R, Tomczak AA, Czernikiewicz A, Walecki J.

Med Sci Monit. 2007 May;13 Suppl 1:17-22.

PMID:
17507880
[PubMed - indexed for MEDLINE]
6.

Reduced NAA in the thalamus and altered membrane and glial metabolism in schizophrenic patients detected by 1H-MRS and tissue segmentation.

Auer DP, Wilke M, Grabner A, Heidenreich JO, Bronisch T, Wetter TC.

Schizophr Res. 2001 Oct 1;52(1-2):87-99.

PMID:
11595395
[PubMed - indexed for MEDLINE]
7.

Diffusion tensor imaging (DTI) and proton magnetic resonance spectroscopy (1H MRS) in schizophrenic subjects and normal controls.

Steel RM, Bastin ME, McConnell S, Marshall I, Cunningham-Owens DG, Lawrie SM, Johnstone EC, Best JJ.

Psychiatry Res. 2001 May 30;106(3):161-70.

PMID:
11382538
[PubMed - indexed for MEDLINE]
8.

Proton magnetic resonance spectroscopy and illness stage in schizophrenia--a systematic review and meta-analysis.

Brugger S, Davis JM, Leucht S, Stone JM.

Biol Psychiatry. 2011 Mar 1;69(5):495-503. doi: 10.1016/j.biopsych.2010.10.004. Epub 2010 Dec 8. Review.

PMID:
21145039
[PubMed - indexed for MEDLINE]
9.

Chemical pathology in brain white matter of recently detoxified alcoholics: a 1H magnetic resonance spectroscopy investigation of alcohol-associated frontal lobe injury.

Schweinsburg BC, Taylor MJ, Alhassoon OM, Videen JS, Brown GG, Patterson TL, Berger F, Grant I.

Alcohol Clin Exp Res. 2001 Jun;25(6):924-34.

PMID:
11410730
[PubMed - indexed for MEDLINE]
10.

Preliminary study of frontal lobe 1H MR spectroscopy in childhood-onset schizophrenia.

Thomas MA, Ke Y, Levitt J, Caplan R, Curran J, Asarnow R, McCracken J.

J Magn Reson Imaging. 1998 Jul-Aug;8(4):841-6.

PMID:
9702885
[PubMed - indexed for MEDLINE]
11.

Common pattern of cortical pathology in childhood-onset and adult-onset schizophrenia as identified by proton magnetic resonance spectroscopic imaging.

Bertolino A, Kumra S, Callicott JH, Mattay VS, Lestz RM, Jacobsen L, Barnett IS, Duyn JH, Frank JA, Rapoport JL, Weinberger DR.

Am J Psychiatry. 1998 Oct;155(10):1376-83.

PMID:
9766769
[PubMed - indexed for MEDLINE]
12.

Quantitative magnetic resonance spectroscopy of schizophrenia: relationship between decreased N-acetylaspartate and frontal lobe dysfunction.

Tanaka Y, Obata T, Sassa T, Yoshitome E, Asai Y, Ikehira H, Suhara T, Okubo Y, Nishikawa T.

Psychiatry Clin Neurosci. 2006 Jun;60(3):365-72.

PMID:
16732755
[PubMed - indexed for MEDLINE]
13.

Regionally specific neuronal pathology in untreated patients with schizophrenia: a proton magnetic resonance spectroscopic imaging study.

Bertolino A, Callicott JH, Elman I, Mattay VS, Tedeschi G, Frank JA, Breier A, Weinberger DR.

Biol Psychiatry. 1998 May 1;43(9):641-8.

PMID:
9582997
[PubMed - indexed for MEDLINE]
14.

Proton magnetic resonance spectroscopy of the human brain in schizophrenia.

Deicken RF, Johnson C, Pegues M.

Rev Neurosci. 2000;11(2-3):147-58. Review.

PMID:
10718151
[PubMed - indexed for MEDLINE]
15.

Proton magnetic resonance spectroscopy (H-MRS) studies of schizophrenia.

Rowland L, Bustillo JR, Lauriello J.

Semin Clin Neuropsychiatry. 2001 Apr;6(2):121-30. Review.

PMID:
11296312
[PubMed - indexed for MEDLINE]
16.

Thalamic abnormalities in patients with schizophrenia revealed by proton magnetic resonance spectroscopy.

Omori M, Murata T, Kimura H, Koshimoto Y, Kado H, Ishimori Y, Ito H, Wada Y.

Psychiatry Res. 2000 May 15;98(3):155-62.

PMID:
10821998
[PubMed - indexed for MEDLINE]
17.

A short echo proton magnetic resonance spectroscopy study of the left mesial-temporal lobe in first-onset schizophrenic patients.

Bartha R, al-Semaan YM, Williamson PC, Drost DJ, Malla AK, Carr TJ, Densmore M, Canaran G, Neufeld RW.

Biol Psychiatry. 1999 Jun 1;45(11):1403-11.

PMID:
10356621
[PubMed - indexed for MEDLINE]
18.

Proton magnetic resonance spectroscopy in subjects at risk for schizophrenia.

Jessen F, Scherk H, Träber F, Theyson S, Berning J, Tepest R, Falkai P, Schild HH, Maier W, Wagner M, Block W.

Schizophr Res. 2006 Oct;87(1-3):81-8. Epub 2006 Jul 13.

PMID:
16842971
[PubMed - indexed for MEDLINE]
19.

Reduced hippocampal N-acetylaspartate without volume loss in schizophrenia.

Deicken RF, Pegues M, Amend D.

Schizophr Res. 1999 Jun 22;37(3):217-23.

PMID:
10403193
[PubMed - indexed for MEDLINE]
20.

[Clinical and neuropsychological correlates of proton magnetic resonance spectroscopy detected metabolites in brains of first-episode and schizophrenic patients].

Szulc A, Galińska B, Tarasów E, Walecki J, Dzienis W, Kubas B, Czernikiewicz A.

Psychiatr Pol. 2003 Nov-Dec;37(6):977-88. Polish.

PMID:
14727370
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk